In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes through) become one company, combining Recursion’s expertise in biology with Exscientia’s focus on chemistry.
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Configure external DNS servers (AWS Route53, Google CloudDNS and others) for Kubernetes Ingresses and Services ...
Proudly serving the Internet community since 1999 with core infrastructure tools for DNS and BGP.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback